PROBIOTIC BLEND — 30 Billion CFU
Synbæctive® (SYNBALANCE SRL) + Bacillus coagulans · measured at manufacture
Five strains, each selected for its research profile and role.
Lactobacillus rhamnosus GG — 5 Billion CFU
Among the most extensively documented probiotic strains in existence, with over 1,000 published studies and numerous randomised controlled trials.
Lactiplantibacillus plantarum PBS067 (DSM24937) — 10 Billion CFU
From one of the most researched probiotic species; a defined, deposited strain within the Synbæctive® platform.
Bifidobacterium animalis subsp. lactis BL050 (DSM 25566) — 7.5 Billion CFU
From one of the most studied Bifidobacterium species, researched across gut transit and digestive-comfort endpoints.
Bifidobacterium longum BLG240 (LMG P-29511) — 5 Billion CFU
A species naturally present in the human gut; a defined, deposited strain chosen for formulation compatibility.
Bacillus coagulans (spore-based) — 2.5 Billion CFU
Structurally distinct from the strains above. Spore-forming bacteria produce endospores — a protective structure that keeps the organism stable under stress, including the acidity of the stomach. This gives inherent stability through digestion, independent of the capsule. Studied across a range of digestive and microbiome endpoints.